{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:03:25Z","timestamp":1784203405443,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The molecular mechanisms by which mutant huntingtin (mHTT) drives pathogenesis in Huntington\u2019s disease (HD) remain incompletely defined. Here we show that neurogenesis is disrupted at multiple stages of lineage progression in both rodent and human neural stem cell (NSC) models of HD. We identify a previously unrecognized phenotype characterized by aberrant expansion of early multipotent progenitors coupled to a profound defect in astrogliogenesis, whereby HD astrocytes fail to express glial fibrillary acidic protein (GFAP). Mechanistically, this defect arises from dysregulation of an epigenetic regulatory axis involving EZH2 and LIN28 upregulation together with reduced expression of the mature let-7g microRNA. Epigenetic pharmacological interventions, targeting this pathway at distinct nodes\u2014through EZH2 modulation, let-7g restoration, or LIN28 inhibition\u2014rescued astroglial differentiation in human HD cells and improved motor function in a Drosophila HD model. Our findings suggest that mHTT might trigger a dual-phase astroglial failure: an early developmental impairment followed by a collapse of regenerative gliogenesis. This bimodal mechanism proposes astrocytic dysfunction as a central driver of HD pathogenesis. Finally, we identify a panel of clinically relevant epigenetic compounds that, by converging on distinct targets within this axis, hold promise for stage-spanning therapeutic strategies capable of modifying disease trajectory.<\/jats:p>","DOI":"10.1038\/s41418-026-01812-8","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:16:38Z","timestamp":1784193398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutant Huntingtin disrupts neurogenic and astroglial programs via the EZH2\u2013Let-7g\u2013LIN28 axis with rescue by epigenetic modulators"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-386X","authenticated-orcid":false,"given":"JD","family":"Rosati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casamassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ruotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMG","family":"Giovenale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rotundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u2019Anzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bergonzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Visioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5682-0823","authenticated-orcid":false,"given":"I.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RM","family":"Carletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Cappucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Migazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ciavarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bertollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-2080","authenticated-orcid":false,"given":"V.","family":"Giambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-8062","authenticated-orcid":false,"given":"A.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rotili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-607X","authenticated-orcid":false,"given":"S.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Binda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gelati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Squitieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-9854","authenticated-orcid":false,"given":"D.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1434-3648","authenticated-orcid":false,"given":"S.","family":"Di Angelantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9202","authenticated-orcid":false,"given":"M.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-2382","authenticated-orcid":false,"given":"A.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9278-8960","authenticated-orcid":false,"given":"M.","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8634-0767","authenticated-orcid":false,"given":"M.","family":"Pennuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AL","family":"Vescovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"1812_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1017\/S1355617707070671","volume":"13","author":"Sean C Hinton","year":"2007","unstructured":"Hinton Sean C, Paulsen Jane S, Hoffmann Raymond G, Reynolds Norman C, Zimbelman Janice L, Rao Stephen M. Motor timing variability increases in preclinical Huntington\u2019s disease patients as the estimated onset of motor symptoms approaches. J Int Neuropsychol Soc. 2007;13:539\u2013543.","journal-title":"J Int Neuropsychol Soc"},{"key":"1812_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the Predict-HD study. Biol Psychiatry. 2007;62:1341\u20131346.","journal-title":"Biol Psychiatry"},{"key":"1812_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","volume":"45","author":"AC Solomon","year":"2007","unstructured":"Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, et al. Verbal episodic memory declines prior to diagnosis in Huntington\u2019s disease. Neuropsychologia. 2007;45:1767\u20131776.","journal-title":"Neuropsychologia"},{"key":"1812_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78:690\u2013695.","journal-title":"Neurology"},{"key":"1812_CR5","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1176\/appi.ajp.2007.06081266","volume":"164","author":"P Nopoulos","year":"2007","unstructured":"Nopoulos P, Magnotta VA, Mikos A, Paulson H, Andreasen NC, Paulsen JS. Morphology of the cerebral cortex in preclinical Huntington\u2019s disease. Am J Psychiatry. 2007;164:1428\u20131434.","journal-title":"Am J Psychiatry"},{"key":"1812_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry. 2001;71:310\u2013314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1812_CR7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.33588\/rn.3211.2000158","volume":"32","author":"MS Barquero-Jim\u00e9nez","year":"2001","unstructured":"Barquero-Jim\u00e9nez MS, G\u00f3mez-Tortosa E. [Cognitive disorders in patients with Huntington\u2019s disease]. Rev Neurol. 2001;32:1067\u20131071.","journal-title":"Rev Neurol"},{"key":"1812_CR8","doi-asserted-by":"crossref","first-page":"e1021","DOI":"10.1212\/WNL.0000000000008066","volume":"93","author":"E van der Plas","year":"2019","unstructured":"van der Plas E, Langbehn DR, Conrad AL, Koscik TR, Tereshchenko A, Epping EA, et al. Abnormal brain development in child and adolescent carriers of mutant huntingtin. Neurology. 2019;93:e1021\u2013e1030.","journal-title":"Neurology"},{"key":"1812_CR9","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/mds.29227","volume":"37","author":"JL Schultz","year":"2022","unstructured":"Schultz JL, Epping EA, van der Plas E, Magnotta VA, Nopoulos PC. Striatal development in early-onset Huntington\u2019s disease. Mov Disord. 2022;37:2459\u20132460.","journal-title":"Mov Disord"},{"key":"1812_CR10","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1093\/brain\/awad275","volume":"146","author":"C Estevez-Fraga","year":"2023","unstructured":"Estevez-Fraga C, Altmann A, Parker CS, Scahill RI, Costa B, Chen Z, et al. Genetic topography and cortical cell loss in Huntington\u2019s disease link development and neurodegeneration. Brain. 2023;146:4532\u20134546.","journal-title":"Brain"},{"key":"1812_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","volume":"22","author":"TB Stoker","year":"2022","unstructured":"Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA. Huntington\u2019s disease: diagnosis and management. Pr Neurol. 2022;22:32\u201341.","journal-title":"Pr Neurol"},{"key":"1812_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cels.2022.03.003","volume":"13","author":"LE Dionisio","year":"2022","unstructured":"Dionisio LE, Yang XW. Group dynamics goes awry: PolyQ-expanded huntingtin gains unwanted partners. Cell Syst. 2022;13:268\u2013270.","journal-title":"Cell Syst"},{"key":"1812_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jnc.15726","volume":"164","author":"H Xu","year":"2023","unstructured":"Xu H, Bensalel J, Raju S, Capobianco E, Lu ML, Wei J. Characterization of huntingtin interactomes and their dynamic responses in living cells by proximity proteomics. J Neurochem. 2023;164:512\u2013528.","journal-title":"J Neurochem"},{"key":"1812_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad214","volume":"5","author":"CF Liu","year":"2023","unstructured":"Liu CF, Younes L, Tong XJ, Hinkle JT, Wang M, Phatak S, et al. Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington\u2019s disease. Brain Commun. 2023;5:fcad214.","journal-title":"Brain Commun"},{"key":"1812_CR15","doi-asserted-by":"crossref","unstructured":"M\u00e4tlik K, Baffuto M, Kus L, Davis DA, Paul MR, Carroll TS, et al. Cell type-specific CAG repeat expansions and toxicity of mutant huntingtin in human striatum and cerebellum. Nat Genet. 2024;56:383\u2013394.","DOI":"10.1038\/s41588-024-01653-6"},{"key":"1812_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JPG Vonsattel","year":"2011","unstructured":"Vonsattel JPG, Keller C, Cortes Ramirez EP. Huntington\u2019s disease - neuropathology. Handb Clin Neurol. 2011;100:83\u2013100.","journal-title":"Handb Clin Neurol"},{"key":"1812_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG. Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: a mechanistic approach. Curr Neuropharmacol. 2020;18:918\u2013935.","journal-title":"Curr Neuropharmacol"},{"key":"1812_CR18","doi-asserted-by":"crossref","unstructured":"Mor A, Tankiewicz-Kwedlo A, Krupa A, Pawlak D. Role of the kynurenine pathway in oxidative stress during neurodegenerative disorders. Cells. 2021;10:1603.","DOI":"10.3390\/cells10071603"},{"key":"1812_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama TH, Waldvogel HJ, Faull RLM, Kwakowsky A. The role of microglia and astrocytes in Huntington\u2019s disease. Front Mol Neurosci. 2019;12:258.","journal-title":"Front Mol Neurosci"},{"key":"1812_CR20","doi-asserted-by":"publisher","first-page":"104963","DOI":"10.1016\/j.nbd.2020.104963","volume":"143","author":"DK Wilton","year":"2020","unstructured":"Wilton DK, Stevens B. The contribution of glial cells to Huntington\u2019s disease pathogenesis. Neurobiol Dis. 2020;143:104963.","journal-title":"Neurobiol Dis"},{"key":"1812_CR21","doi-asserted-by":"publisher","first-page":"e07808","DOI":"10.1016\/j.heliyon.2021.e07808","volume":"7","author":"JB Henningsen","year":"2021","unstructured":"Henningsen JB, Soylu-Kucharz R, Bj\u00f6rkqvist M, Peters\u00e9n \u00c5. Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease. Heliyon. 2021;7:e07808.","journal-title":"Heliyon"},{"key":"1812_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.baga.2012.04.029","volume":"2","author":"AM Estrada-S\u00e1nchez","year":"2012","unstructured":"Estrada-S\u00e1nchez AM, Rebec GV. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington\u2019s disease: interactions between neurons and astrocytes. Basal Ganglia. 2012;2:57\u201366.","journal-title":"Basal Ganglia"},{"key":"1812_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, et al. Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry. 2006;59:57\u201363.","journal-title":"Biol Psychiatry"},{"key":"1812_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-021-02269-4","volume":"141","author":"RA Hickman","year":"2021","unstructured":"Hickman RA, Faust PL, Rosenblum MK, Marder K, Mehler MF, Vonsattel JP. Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains. Acta Neuropathol. 2021;141:399\u2013413.","journal-title":"Acta Neuropathol"},{"key":"1812_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.aax3338","volume":"369","author":"M Barnat","year":"2020","unstructured":"Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, et al. Huntington\u2019s disease alters human neurodevelopment. Science. 2020;369:787\u2013793.","journal-title":"Science"},{"key":"1812_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35388-x","volume":"13","author":"RG Lim","year":"2022","unstructured":"Lim RG, Al-Dalahmah O, Wu J, Gold MP, Reidling JC, Tang G, et al. Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation. Nat Commun. 2022;13:7791.","journal-title":"Nat Commun"},{"key":"1812_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-114","volume":"11","author":"Z Kohl","year":"2010","unstructured":"Kohl Z, Regensburger M, Aigner R, Kandasamy M, Winner B, Aigner L, et al. Impaired adult olfactory bulb neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease. BMC Neurosci. 2010;11:114.","journal-title":"BMC Neurosci"},{"key":"1812_CR28","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","volume":"25","author":"W Phillips","year":"2005","unstructured":"Phillips W, Morton AJ, Barker RA. Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease are attributable to the in vivo microenvironment. J Neurosci. 2005;25:11564\u201311576.","journal-title":"J Neurosci"},{"key":"1812_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbadis.2017.09.009","volume":"1864","author":"AC Silva","year":"2018","unstructured":"Silva AC, Ferreira IL, Hayden MR, Ferreiro E, Rego AC. Characterization of subventricular zone-derived progenitor cells from the mild and late symptomatic YAC128 mouse model of Huntington\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2018;1864:34\u201344.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1812_CR30","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1073\/pnas.1532244100","volume":"100","author":"MA Curtis","year":"2003","unstructured":"Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, Dragunow M, et al. Increased cell proliferation and neurogenesis in the adult human Huntington\u2019s disease brain. Proc Natl Acad Sci USA. 2003;100:9023\u20139027.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1812_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/dneu.22028","volume":"72","author":"MA Curtis","year":"2012","unstructured":"Curtis MA, Low VF, Faull RLM. Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation. Dev Neurobiol. 2012;72:990\u20131005.","journal-title":"Dev Neurobiol"},{"key":"1812_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.neuroscience.2004.12.051","volume":"132","author":"MA Curtis","year":"2005","unstructured":"Curtis MA, Penney EB, Pearson J, Dragunow M, Connor B, Faull RL. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington\u2019s disease human brain. Neuroscience. 2005;132:777\u2013788.","journal-title":"Neuroscience"},{"key":"1812_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2013.04.030","volume":"1518","author":"MH McCollum","year":"2013","unstructured":"McCollum MH, Leon RT, Rush DB, Guthrie KM, Wei J. Striatal oligodendrogliogenesis and neuroblast recruitment are increased in the R6\/2 mouse model of Huntington\u2019s disease. Brain Res. 2013;1518:91\u2013103.","journal-title":"Brain Res"},{"key":"1812_CR34","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","volume":"25","author":"AL Southwell","year":"2016","unstructured":"Southwell AL, Smith-Dijak A, Kay C, Sepers M, Villanueva EB, Parsons MP, et al. An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes. Hum Mol Genet. 2016;25:3654\u20133675.","journal-title":"Hum Mol Genet"},{"key":"1812_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol. 2003;465:11\u201326.","journal-title":"J Comp Neurol"},{"key":"1812_CR36","doi-asserted-by":"publisher","first-page":"e0123527","DOI":"10.1371\/journal.pone.0123527","volume":"10","author":"N Carty","year":"2015","unstructured":"Carty N, Berson N, Tillack K, Thiede C, Scholz D, Kottig K, et al. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington\u2019s disease: an in vivo high-content imaging study. PLoS ONE. 2015;10:e0123527.","journal-title":"PLoS ONE"},{"key":"1812_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-59745-133-8_7","volume":"438","author":"R Galli","year":"2008","unstructured":"Galli R, Gritti A, Vescovi AL. Adult neural stem cells. Methods Mol Biol. 2008;438:67\u201384.","journal-title":"Methods Mol Biol"},{"key":"1812_CR38","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1523\/JNEUROSCI.16-03-01091.1996","volume":"16","author":"A Gritti","year":"1996","unstructured":"Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, et al. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci. 1996;16:1091\u20131100.","journal-title":"J Neurosci"},{"key":"1812_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.stem.2018.11.010","volume":"24","author":"M Osipovitch","year":"2019","unstructured":"Osipovitch M, Asenjo Martinez A, Mariani JN, Cornwell A, Dhaliwal S, Zou L, et al. Human ESC-derived chimeric mouse models of Huntington\u2019s disease reveal cell-intrinsic defects in glial progenitor cell differentiation. Cell Stem Cell. 2019;24:107\u2013122.e7.","journal-title":"Cell Stem Cell"},{"key":"1812_CR40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","volume":"85","author":"B Huang","year":"2015","unstructured":"Huang B, Wei W, Wang G, Gaertig MA, Feng Y, Wang W, et al. Mutant Huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron. 2015;85:1212\u20131226.","journal-title":"Neuron"},{"key":"1812_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/nyas.14977","volume":"1522","author":"BS Khakh","year":"2023","unstructured":"Khakh BS, Goldman SA. Astrocytic contributions to Huntington\u2019s disease pathophysiology. Ann NY Acad Sci. 2023;1522:42\u201359.","journal-title":"Ann NY Acad Sci"},{"key":"1812_CR42","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1073\/pnas.1818042116","volume":"116","author":"C Ferrari Bardile","year":"2019","unstructured":"Ferrari Bardile C, Garcia-Miralles M, Caron NS, Rayan NA, Langley SR, Harmston N, et al. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease. Proc Natl Acad Sci USA. 2019;116:9622\u20139627.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1812_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.scr.2018.01.011","volume":"27","author":"J Rosati","year":"2018","unstructured":"Rosati J, Bidollari E, Rotundo G, Ferrari D, Torres B, Bernardini L, et al. Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington disease. Stem Cell Res. 2018;27:86\u201389.","journal-title":"Stem Cell Res"},{"key":"1812_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.scr.2018.02.014","volume":"28","author":"E Bidollari","year":"2018","unstructured":"Bidollari E, Rotundo G, Ferrari D, Candido O, Bernardini L, Consoli F, et al. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington\u2019s disease at the presymptomatic stage. Stem Cell Res. 2018;28:145\u2013148.","journal-title":"Stem Cell Res"},{"key":"1812_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.scr.2018.04.008","volume":"29","author":"G Rotundo","year":"2018","unstructured":"Rotundo G, Bidollari E, Ferrari D, Spasari I, Bernardini L, Consoli F, et al. Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile-Onset Huntington\u2019s disease. Stem Cell Res. 2018;29:174\u2013178.","journal-title":"Stem Cell Res"},{"key":"1812_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/7651_2021_440","volume":"2520","author":"L Isaja","year":"2022","unstructured":"Isaja L, Ferriol-Laffouillere SL, Mucci S, Rodr\u00edguez-Varela MS, Romorini L. Embryoid bodies-based multilineage differentiation of human embryonic stem cells grown on feeder-free conditions. Methods Mol Biol. 2022;2520:189\u2013198.","journal-title":"Methods Mol Biol"},{"key":"1812_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0990-2","volume":"9","author":"J Rosati","year":"2018","unstructured":"Rosati J, Ferrari D, Altieri F, Tardivo S, Ricciolini C, Fusilli C, et al. Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies. Cell Death Dis. 2018;9:937.","journal-title":"Cell Death Dis"},{"key":"1812_CR48","doi-asserted-by":"crossref","unstructured":"Miyashita S, Hoshino M. Transit amplifying progenitors in the cerebellum: similarities to and differences from transit amplifying cells in other brain regions and between species. Cells 2022;11:726.","DOI":"10.3390\/cells11040726"},{"key":"1812_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.stem.2022.12.007","volume":"30","author":"Y Su","year":"2023","unstructured":"Su Y, Zhou Y, Bennett ML, Li S, Carceles-Cordon M, Lu L, et al. A single-cell transcriptome atlas of glial diversity in the human hippocampus across the postnatal lifespan. Cell Stem Cell. 2023;30:113.","journal-title":"Cell Stem Cell"},{"key":"1812_CR50","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/hmg\/ddx259","volume":"26","author":"D Tripathy","year":"2017","unstructured":"Tripathy D, Vignoli B, Ramesh N, Polanco MJ, Coutelier M, Stephen CD, et al. Mutations in TGM6 induce the unfolded protein response in SCA35. Hum Mol Genet. 2017;26:3749\u20133762.","journal-title":"Hum Mol Genet"},{"key":"1812_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108980","volume":"35","author":"A Migazzi","year":"2021","unstructured":"Migazzi A, Scaramuzzino C, Anderson EN, Tripathy D, Hern\u00e1ndez IH, Grant RA, et al. Huntingtin-mediated axonal transport requires arginine methylation by PRMT6. Cell Rep. 2021;35:108980.","journal-title":"Cell Rep"},{"key":"1812_CR52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/hmg\/ddp524","volume":"19","author":"IS Seong","year":"2010","unstructured":"Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, Woo CJ, et al. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet. 2010;19:573\u2013583.","journal-title":"Hum Mol Genet"},{"key":"1812_CR53","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/emboj.2013.93","volume":"32","author":"A Sparmann","year":"2013","unstructured":"Sparmann A, Xie Y, Verhoeven E, Vermeulen M, Lancini C, Gargiulo G, et al. The chromodomain helicase Chd4 is required for Polycomb-mediated inhibition of astroglial differentiation. EMBO J. 2013;32:1598\u20131612.","journal-title":"EMBO J"},{"key":"1812_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2022.194840","volume":"1865","author":"SH Barghout","year":"2022","unstructured":"Barghout SH, Machado RAC, Barsyte-Lovejoy D. Chemical biology and pharmacology of histone lysine methylation inhibitors. Biochim Biophys Acta Gene Regul Mech. 2022;1865:194840.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"1812_CR55","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1073\/pnas.1303800110","volume":"110","author":"SK Knutson","year":"2013","unstructured":"Knutson SK, Warholic NM, Wigle TJ, Klaus CR, Allain CJ, Raimondi A, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci USA. 2013;110:7922\u20137927.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1812_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2019.09.002","volume":"36","author":"ZA Qadeer","year":"2019","unstructured":"Qadeer ZA, Valle-Garcia D, Hasson D, Sun Z, Cook A, Nguyen C, et al. ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures. Cancer Cell. 2019;36:512\u2013527.e9.","journal-title":"Cancer Cell"},{"key":"1812_CR57","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1073\/pnas.1703966114","volume":"114","author":"T Januario","year":"2017","unstructured":"Januario T, Ye X, Bainer R, Alicke B, Smith T, Haley B, et al. PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI\/SNF mutant tumors. Proc Natl Acad Sci USA. 2017;114:12249\u201312254.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1812_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41589-019-0421-4","volume":"16","author":"A Ma","year":"2020","unstructured":"Ma A, Stratikopoulos E, Park KS, Wei J, Martin TC, Yang X, et al. Discovery of a first-in-class EZH2 selective degrader. Nat Chem Biol. 2020;16:214\u2013222.","journal-title":"Nat Chem Biol"},{"key":"1812_CR59","doi-asserted-by":"crossref","unstructured":"Guajardo L, Aguilar R, Bustos FJ, Nardocci G, Guti\u00e9rrez RA, van Zundert B, et al. Downregulation of the polycomb-associated methyltransferase Ezh2 during maturation of hippocampal neurons is mediated by microRNAs Let-7 and miR-124. Int J Mol S. 2020;21:8472.","DOI":"10.3390\/ijms21228472"},{"key":"1812_CR60","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature12119","volume":"497","author":"HM Chang","year":"2013","unstructured":"Chang HM, Triboulet R, Thornton JE, Gregory RI. A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway. Nature. 2013;497:244\u2013248.","journal-title":"Nature"},{"key":"1812_CR61","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1261\/rna.040055.113","volume":"19","author":"D Ustianenko","year":"2013","unstructured":"Ustianenko D, Hrossova D, Potesil D, Chalupnikova K, Hrazdilova K, Pachernik J, et al. Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs. RNA. 2013;19:1632\u20131638.","journal-title":"RNA"},{"key":"1812_CR62","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1021\/acschembio.6b00232","volume":"11","author":"M Roos","year":"2016","unstructured":"Roos M, Prad\u00e8re U, Ngondo RP, Behera A, Allegrini S, Civenni G, et al. A small-molecule inhibitor of Lin28. ACS Chem Biol. 2016;11:2773\u20132781.","journal-title":"ACS Chem Biol"},{"key":"1812_CR63","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/15476286.2015.1058478","volume":"12","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI. Identification of small-molecule inhibitors of Zcchc11 TUTase activity. RNA Biol. 2015;12:792\u2013800.","journal-title":"RNA Biol"},{"key":"1812_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuron.2007.11.025","volume":"57","author":"E Romero","year":"2008","unstructured":"Romero E, Cha GH, Verstreken P, Ly CV, Hughes RE, Bellen HJ, et al. Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron. 2008;57:27\u201340.","journal-title":"Neuron"},{"key":"1812_CR65","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0012-1606(88)90139-X","volume":"126","author":"S Robinow","year":"1988","unstructured":"Robinow S, White K. The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev Biol. 1988;126:294\u2013303.","journal-title":"Dev Biol"},{"key":"1812_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jneumeth.2015.07.026","volume":"265","author":"EA Lewis","year":"2016","unstructured":"Lewis EA, Smith GA. Using Drosophila models of Huntington\u2019s disease as a translatable tool. J Neurosci Methods. 2016;265:89\u201398.","journal-title":"J Neurosci Methods"},{"key":"1812_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56030-6","volume":"16","author":"J Oh","year":"2025","unstructured":"Oh J, Catherine C, Kim ES, Min KW, Jeong HC, Kim H, et al. Engineering a membrane protein chaperone to ameliorate the proteotoxicity of mutant huntingtin. Nat Commun. 2025;16:737.","journal-title":"Nat Commun"},{"key":"1812_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58618-4","volume":"16","author":"ZhefanStephen Chen","year":"2025","unstructured":"Chen ZhefanStephen, Peng ShaohongIsaac, Leong Lok I, Gall-Duncan Terence, Wong Nathan Siu Jun, Li Tsz Ho, et al. Mutant huntingtin induces neuronal apoptosis via derepressing the non-canonical poly(A) polymerase PAPD5. Nat Commun. 2025;16:3307.","journal-title":"Nat Commun"},{"key":"1812_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, et al. SUMO modification of Huntingtin and Huntington\u2019s disease pathology. Science. 2004;304:100\u2013104.","journal-title":"Science"},{"key":"1812_CR70","doi-asserted-by":"publisher","first-page":"268ra178","DOI":"10.1126\/scitranslmed.3010523","volume":"6","author":"XH Lu","year":"2014","unstructured":"Lu XH, Mattis VB, Wang N, Al-Ramahi I, van den Berg N, Fratantoni SA, et al. Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease. Sci Transl Med. 2014;6:268ra178.","journal-title":"Sci Transl Med"},{"key":"1812_CR71","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1126\/science.1139517","volume":"315","author":"J Jung","year":"2007","unstructured":"Jung J, Bonini N. CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science. 2007;315:1857\u20131859.","journal-title":"Science"},{"key":"1812_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07524-0","volume":"16","author":"Thomas J Krzystek","year":"2025","unstructured":"Krzystek Thomas J, Rathnayake Rasika, Zeng Jia, Huang Jing, Iacobucci Gary, Yu Michael C, et al. Opposing roles for GSK3\u03b2 and ERK1-dependent phosphorylation of huntingtin during neuronal dysfunction and cell death in Huntington\u2019s disease. Cell Death Dis. 2025;16:328.","journal-title":"Cell Death Dis"},{"key":"1812_CR73","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrn751","volume":"3","author":"MM Muqit","year":"2002","unstructured":"Muqit MM, Feany MB. Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Nat Rev Neurosci. 2002;3:237\u2013243.","journal-title":"Nat Rev Neurosci"},{"key":"1812_CR74","doi-asserted-by":"publisher","unstructured":"Madabattula ST, Strautman JC, Bysice AM, O\u2019Sullivan JA, Androschuk A, Rosenfelt C, et al. Quantitative analysis of climbing defects in a Drosophila model of neurodegenerative disorders. J Vis Exp 2015;e52741. https:\/\/doi.org\/10.3791\/52741.","DOI":"10.3791\/52741"},{"key":"1812_CR75","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0012-1606(03)00126-X","volume":"258","author":"EG Moss","year":"2003","unstructured":"Moss EG, Tang L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev Biol. 2003;258:432\u2013442.","journal-title":"Dev Biol"},{"key":"1812_CR76","doi-asserted-by":"crossref","unstructured":"Makeeva VS, Dyrkheeva NS, Lavrik OI, Zakian SM, Malakhova AA. Mutant-Huntingtin molecular pathways elucidate new targets for drug repurposing. Int J Mol Sci. 2023;24:16798.","DOI":"10.3390\/ijms242316798"},{"key":"1812_CR77","doi-asserted-by":"crossref","unstructured":"Jurcau A. Molecular pathophysiological mechanisms in Huntington\u2019s disease. Biomedicines 2022;10:1432.","DOI":"10.3390\/biomedicines10061432"},{"key":"1812_CR78","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.molmed.2023.07.010","volume":"29","author":"C Ferrari Bardile","year":"2023","unstructured":"Ferrari Bardile C, Radulescu CI, Pouladi MA. Oligodendrocyte pathology in Huntington\u2019s disease: from mechanisms to therapeutics. Trends Mol Med. 2023;29:802\u2013816.","journal-title":"Trends Mol Med"},{"key":"1812_CR79","first-page":"377","volume":"10","author":"C Ferrari Bardile","year":"2021","unstructured":"Ferrari Bardile C, Sidik H, Quek R, Yusof NABM, Garcia-Miralles M, Pouladi MA. Abnormal spinal cord myelination due to oligodendrocyte dysfunction in a model of Huntington\u2019s disease. J Hunt Dis. 2021;10:377\u2013384.","journal-title":"J Hunt Dis"},{"key":"1812_CR80","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/mds.28109","volume":"35","author":"C Casella","year":"2020","unstructured":"Casella C, Lipp I, Rosser A, Jones DK, Metzler-Baddeley C. A critical review of white matter changes in Huntington\u2019s disease. Mov Disord. 2020;35:1302\u20131311.","journal-title":"Mov Disord"},{"key":"1812_CR81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah O, Sosunov AA, Shaik A, Ofori K, Liu Y, Vonsattel JP, et al. Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathol Commun. 2020;8:19.","journal-title":"Acta Neuropathol Commun"},{"key":"1812_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-5-17","volume":"5","author":"TA Juopperi","year":"2012","unstructured":"Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, et al. Astrocytes generated from patient-induced pluripotent stem cells recapitulate features of Huntington\u2019s disease patient cells. Mol Brain. 2012;5:17.","journal-title":"Mol Brain"},{"key":"1812_CR83","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nn.4360","volume":"19","author":"M von Schimmelmann","year":"2016","unstructured":"von Schimmelmann M, Feinberg PA, Sullivan JM, Ku SM, Badimon A, Duff MK, et al. Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat Neurosci. 2016;19:1321\u20131330.","journal-title":"Nat Neurosci"},{"key":"1812_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-82","volume":"14","author":"K Hirabayashi","year":"2013","unstructured":"Hirabayashi K, Shiota K, Yagi S. DNA methylation profile dynamics of tissue-dependent and differentially methylated regions during mouse brain development. BMC Genomics. 2013;14:82.","journal-title":"BMC Genomics"},{"key":"1812_CR85","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1038\/emboj.2010.117","volume":"29","author":"JD Godin","year":"2010","unstructured":"Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington\u2019s disease. EMBO J. 2010;29:2433\u20132445.","journal-title":"EMBO J"},{"key":"1812_CR86","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf275","volume":"7","author":"P Shahim","year":"2025","unstructured":"Shahim P, AlQahtani A, Kokkinis AD, Kazmi N, Ezuma-Ngwu M, Misra J, et al. CSF and blood neuronal injury biomarkers in spinal bulbar muscular atrophy and amyotrophic lateral sclerosis 4. Brain Commun. 2025;7:fcaf275.","journal-title":"Brain Commun"},{"key":"1812_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14612","volume":"21","author":"Q Tian","year":"2025","unstructured":"Tian Q, Greig EE, Walker KA, Duggan MR, Yang Z, Moghekar A, et al. Longitudinal patterns of brain aging and neurodegeneration among older adults with dual decline in memory and gait. Alzheimers Dement. 2025;21:e14612.","journal-title":"Alzheimers Dement"},{"key":"1812_CR88","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/jnr.24977","volume":"99","author":"A Sood","year":"2021","unstructured":"Sood A, Preeti K, Fernandes V, Khatri DK, Singh SB. Glia: a major player in glutamate-GABA dysregulation-mediated neurodegeneration. J Neurosci Res. 2021;99:3148\u20133189.","journal-title":"J Neurosci Res"},{"key":"1812_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106554","volume":"198","author":"AYS Tan","year":"2024","unstructured":"Tan AYS, Tippett LJ, Turner CP, Swanson MEV, Park TIH, Curtis MA, et al. Microglial proliferation and astrocytic protein alterations in the human Huntington\u2019s disease cortex. Neurobiol Dis. 2024;198:106554.","journal-title":"Neurobiol Dis"},{"key":"1812_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-443-19102-2.00013-2","volume":"210","author":"A Verkhratsky","year":"2025","unstructured":"Verkhratsky A, Hol EM, de Witte LD, Aronica E. General pathophysiology of neuroglia. Handb Clin Neurol. 2025;210:3\u20137.","journal-title":"Handb Clin Neurol"},{"key":"1812_CR91","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u2013408.","journal-title":"Methods"},{"key":"1812_CR92","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/path.1645","volume":"204","author":"M Pekny","year":"2004","unstructured":"Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol. 2004;204:428\u2013437.","journal-title":"J Pathol"},{"key":"1812_CR93","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0896-6273(00)80194-4","volume":"17","author":"W Liedtke","year":"1996","unstructured":"Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron. 1996;17:607\u2013615.","journal-title":"Neuron"},{"key":"1812_CR94","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26:2363\u20132367.","journal-title":"Bioinformatics"},{"key":"1812_CR95","doi-asserted-by":"publisher","unstructured":"Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3. https:\/\/doi.org\/10.2202\/1544-6115.1027.","DOI":"10.2202\/1544-6115.1027"},{"key":"1812_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1:e90.","journal-title":"Curr Protoc"},{"key":"1812_CR97","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.stem.2018.08.018","volume":"23","author":"V Giambra","year":"2018","unstructured":"Giambra V, Gusscott S, Gracias D, Song R, Lam SH, Panelli P, et al. Epigenetic restoration of fetal-like IGF1 signaling inhibits leukemia stem cell activity. Cell Stem Cell. 2018;23:714\u2013726.e7.","journal-title":"Cell Stem Cell"},{"key":"1812_CR98","first-page":"25","volume":"4","author":"J Kim","year":"2018","unstructured":"Kim J, Lee Y, Lu X, Song B, Fong KW, Cao Q, et al. Polycomb- and methylation-independent roles of EZH2 as a transcription activator. Cell Rep. 2018;4:25.","journal-title":"Cell Rep"},{"key":"1812_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2024.142440","volume":"361","author":"U Cappucci","year":"2024","unstructured":"Cappucci U, Proietti M, Casale AM, Schiavo S, Chiavarini S, Accardo S, et al. Assessing genotoxic effects of plastic leachates in Drosophila melanogaster. Chemosphere. 2024;361:142440.","journal-title":"Chemosphere"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01812-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:07:19Z","timestamp":1784200039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01812-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":99,"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01812-8","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JDR and ALV are co-inventors of the patent P2474IT for which they retain no rights of commercial exploitation.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experimental methods used in this study were performed in full compliance with the relevant specifications, guidelines, and administrative regulations, as described in the respective sections.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}